Glycine N-methyltransferase deficiency in female mice impairs insulin signaling and promotes gluconeogenesis by modulating the PI3K/Akt pathway in the liver

[1]  J. Shaw,et al.  IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. , 2011, Diabetes research and clinical practice.

[2]  F. Jornayvaz,et al.  Metabolic syndrome and nonalcoholic fatty liver disease: Is insulin resistance the link? , 2015, Molecular and Cellular Endocrinology.

[3]  E. Quinlivan,et al.  Dysregulated Hepatic Methionine Metabolism Drives Homocysteine Elevation in Diet-Induced Nonalcoholic Fatty Liver Disease , 2015, PloS one.

[4]  Shelly C. Lu,et al.  S-Adenosylmethionine increases circulating very-low density lipoprotein clearance in non-alcoholic fatty liver disease. , 2015, Journal of hepatology.

[5]  K. Petersen,et al.  The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes , 2014, Nature.

[6]  G. Shulman,et al.  Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 Diabetes , 2014, Hepatology.

[7]  R. DeFronzo,et al.  Non-Alcoholic Fatty Liver Disease (NAFLD) and Its Connection with Insulin Resistance, Dyslipidemia, Atherosclerosis and Coronary Heart Disease , 2013, Nutrients.

[8]  R. Medina‐Santillán,et al.  Hepatic manifestations of metabolic syndrome. , 2013, Diabetes/metabolism research and reviews.

[9]  Shiu-Feng Huang,et al.  Glycine N-Methyltransferase Deficiency Affects Niemann-Pick Type C2 Protein Stability and Regulates Hepatic Cholesterol Homeostasis , 2012, Molecular medicine.

[10]  Guido Gerken,et al.  The interaction of hepatic lipid and glucose metabolism in liver diseases. , 2012, Journal of hepatology.

[11]  G. Shulman,et al.  Mechanisms for Insulin Resistance: Common Threads and Missing Links , 2012, Cell.

[12]  Kuen-Feng Chen,et al.  Functional Characterization of Glycine N-Methyltransferase and Its Interactive Protein DEPDC6/DEPTOR in Hepatocellular Carcinoma , 2012, Molecular medicine.

[13]  C. Kahn,et al.  Insulin regulates liver metabolism in vivo in the absence of hepatic Akt and Foxo1 , 2012, Nature Medicine.

[14]  K. Schalinske,et al.  Tissue‐specific alterations of methyl group metabolism with DNA hypermethylation in the Zucker (type 2) diabetic fatty rat , 2012, Diabetes/metabolism research and reviews.

[15]  I. Pogribny,et al.  Molecular alterations in hepatocarcinogenesis induced by dietary methyl deficiency. , 2012, Molecular nutrition & food research.

[16]  K. Nieman,et al.  Insulin administration abrogates perturbation of methyl group and homocysteine metabolism in streptozotocin-treated type 1 diabetic rats. , 2011, American journal of physiology. Endocrinology and metabolism.

[17]  M. Ezzati,et al.  National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants , 2011, The Lancet.

[18]  Shelly C. Lu,et al.  The hepatocarcinogenic effect of methionine and choline deficient diets: an adaptation to the Warburg effect? , 2011, Alcoholism, clinical and experimental research.

[19]  W. D. de Vos,et al.  Do nutrient–gut–microbiota interactions play a role in human obesity, insulin resistance and type 2 diabetes? , 2011, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[20]  Shiu-Feng Huang,et al.  Higher susceptibility to aflatoxin B1‐related hepatocellular carcinoma in glycine N‐methyltransferase knockout mice , 2011, International journal of cancer.

[21]  J. Shaw,et al.  IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. , 2011, Diabetes research and clinical practice.

[22]  Kuan-Hsuan Chen,et al.  Deficiency of glycine N‐methyltransferase results in deterioration of cellular defense to stress in mouse liver , 2010, Proteomics. Clinical applications.

[23]  J. Shaw,et al.  Global estimates of the prevalence of diabetes for 2010 and 2030. , 2010, Diabetes research and clinical practice.

[24]  D. Sabatini,et al.  DEPTOR Is an mTOR Inhibitor Frequently Overexpressed in Multiple Myeloma Cells and Required for Their Survival , 2009, Cell.

[25]  Yan-Hwa Wu Lee,et al.  Characterization of a glycine N‐methyltransferase gene knockout mouse model for hepatocellular carcinoma: Implications of the gender disparity in liver cancer susceptibility , 2009, International journal of cancer.

[26]  H. Tilg,et al.  Insulin resistance, inflammation, and non-alcoholic fatty liver disease , 2008, Trends in Endocrinology & Metabolism.

[27]  M. Birnbaum,et al.  The role of FoxO in the regulation of metabolism , 2008, Oncogene.

[28]  Shelly C. Lu,et al.  Loss of the glycine N‐methyltransferase gene leads to steatosis and hepatocellular carcinoma in mice , 2007, Hepatology.

[29]  M. Hsiao,et al.  Glycine N‐methyltransferase−/− mice develop chronic hepatitis and glycogen storage disease in the liver , 2007, Hepatology.

[30]  C. Kahn,et al.  From mice to men: insights into the insulin resistance syndromes. , 2006, Annual review of physiology.

[31]  F. Maxfield,et al.  Role of cholesterol and lipid organization in disease , 2005, Nature.

[32]  K. Schalinske,et al.  Retinoic acid and glucocorticoid treatment induce hepatic glycine N-methyltransferase and lower plasma homocysteine concentrations in rats and rat hepatoma cells. , 2003, The Journal of nutrition.

[33]  Kuan-Hsuan Chen,et al.  Characterization of reduced expression of glycine N-methyltransferase in cancerous hepatic tissues using two newly developed monoclonal antibodies. , 2003, Journal of biomedical science.

[34]  Marlies K. Ozias,et al.  Activation and induction of glycine N-methyltransferase by retinoids are tissue- and gender-specific. , 2002, Archives of biochemistry and biophysics.

[35]  Yi-Jen Chen,et al.  Characterization of glycine‐N‐methyltransferase‐gene expression in human hepatocellular carcinoma , 1998, International journal of cancer.

[36]  C. Wagner,et al.  Tissue distribution of glycine N-methyltransferase, a major folate-binding protein of liver. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[37]  C. Kahn,et al.  Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein , 1991, Nature.

[38]  R. Cook,et al.  Glycine N-methyltransferase is a folate binding protein of rat liver cytosol. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[39]  S. Kerr.  Competing methyltransferase systems. , 1972, The Journal of biological chemistry.